Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain

Inclusion Criteria: * 18-100 years, inclusive * Diagnosis of episodic migraine with and without aura per International Headache Society diagnostic criteria * 4-14 migraine days per month * Ability to provide informed consent * Demonstrates no contraindication to the use of electrical nerve stimulation * Capable and willing to follow all study-related procedures Exclusion Criteria: * Currently pregnant or breastfeeding, pregnant within the past 6 months or intends to become pregnant during the enrollment period * Diagnosis of chronic migraine or other forms of primary or secondary headache disorders, including medication overuse headache per International Headache Society diagnostic criteria * Any medical condition that would, in the opinion of the investigator, make the subject ineligible * Has received botulinum toxin injections within the past 3 months * Is currently implanted with an electrical and/or neurostimulator devic, including but not limited to cardiac pacemaker or defibrillator, vagal neurostimulator, sacral stimulator, bone growth stimulator, or cochlear implant * Use of investigational drug/device therapy within the past 4 weeks * Deemed unsuitable for enrollment in study by the investigator based on subjects' history or physical examination (including bleeding disorders, anticoagulant medications and peripheral neuropathy) * No changes in preventive medications (or other medications determined to potentially interfere with the study) in the previous 30 days and no intent to change it during the study